Newspaper That Brought Down Theranos Learns Owner Is Major Investor
Once upon a time, Theranos was a promising biotech firm—raising $632 million from 2014-2015. In October 2015, everything changed when the Wall Street Journal published the first of its many exposés that revealed the company’s struggle to develop the blood-testing technology it promised. The Journal’s stories…
Powered by WPeMatico
Our Score
